[1]
T. Yamazhan, “Real-life experience of ledipasvir and sofosbuvir single-tablet regimen among chronic hepatitis C patients in Turkey”, Turkish Journal of Gastroenterology, vol. 31, no. 3, pp. 239–245, Jan. 2020.